Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study

NCT ID: NCT01656772

Last Updated: 2015-07-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the use of a robotic device that is remotely controlled to maneuver a circular mapping catheter in the left atrium during Atrial Fibrillation (AF) ablation procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Key to the success of an electrophysiology procedure is the ability to accurately map, sense and pace the heart. Electrophysiology mapping catheters are available in a variety of shapes and electrode configurations. The majority of these catheters are manipulated manually by the physician. The Vdrive simplifies these manipulations by allowing an operator to mechanically advance, retract, rotate, deflect and maneuver a circular mapping catheter. The circular mapping catheter is not altered in structure, function or indication in the same manner as the predicate device (Cardiodrive Catheter Advancement System).

This is a prospective, randomized, non-blinded, controlled study comparing manual navigation of a circular mapping catheter with mechanical navigation by the Vdrive. A total of 120 patients are expected to complete the study: 80 patients in the Vdrive navigation arm and 40 patients in the manual navigation arm. Patients will be enrolled at a minimum of one site in the European Union where the product is currently marketed and the United States, where the Vdrive is considered to be investigational.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Manual Lasso navigation

Use of conventional manual navigation techniques with the Lasso catheter

Group Type ACTIVE_COMPARATOR

Manual Lasso navigation

Intervention Type PROCEDURE

Manually maneuver a Lasso catheter

Vdrive Lasso navigation

Use of the Vdrive to remotely and robotically control the manipulation of a Lasso catheter

Group Type EXPERIMENTAL

Vdrive Lasso navigation

Intervention Type DEVICE

Remote robotic Lasso navigation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vdrive Lasso navigation

Remote robotic Lasso navigation

Intervention Type DEVICE

Manual Lasso navigation

Manually maneuver a Lasso catheter

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Left atrial AF ablation procedure requiring the use of a Lasso mapping catheter
* Subject must be at least 18 years of age
* Subject must be male, female of no childbearing potential, or a female that has a negative pregnancy test prior to randomization

Exclusion Criteria

* Unable to safely expose subject to a magnetic field
* Prior AF ablation procedure
* Patients with fewer than 4 PVs are excluded
* Patients with persistent AF in whom early recurrence of AF following cardioversion would preclude completion of the pacing maneuvers described in the protocol or patients with other conditions that would similarly preclude completion of the pacing maneuvers
* Contraindication to procedure or unable to return for follow-up
* History of clotting disorder, bleeding abnormalities or contraindication to anticoagulation
* Actively participating in other cardiac device trial(s)
* Currently pregnant
* Under 18 years of age
* Prosthetic valves
* Atrial abnormalities (thrombus, myxoma or baffle)
* Other exclusions per the investigator
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stereotaxis

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Qun Sha, MD

Role: STUDY_DIRECTOR

Stereotaxis Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Central Baptist Hospital

Lexington, Kentucky, United States

Site Status

Texas Cardiac Arrhythmia Institute

Austin, Texas, United States

Site Status

Baylor Research Institute

Dallas, Texas, United States

Site Status

ZNA Campus Middelheim Lindendreef 1

Antwerp, Antwerpen, Belgium

Site Status

IKFE HDZ GbmH

Bad Oeynhausen, Bad Oeynhausen, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLIN-020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.